- Published on
Oncology-Low-Risk Alleles and Cancer Risk
I. Key Concepts:
The text focuses on the discovery of low-risk alleles for colon cancer via GWAS. These SNPs are frequently located in:
The use of GEMMs is crucial in demonstrating the impact of these seemingly insignificant low-risk alleles. Manipulating these SNPs in GEMMs has shown profound effects on tumor development, suggesting that even small genetic variations can contribute substantially to cancer initiation and progression.
IV. Clinical Implications:
The discovery of disease-associated SNPs, even low-risk ones, holds important clinical implications. Individuals carrying these SNPs may require:
I. Key Concepts:
- Genome-Wide Association Studies (GWAS): Large-scale studies that scan the entire genome to identify genetic variations (SNPs) associated with a particular disease. They're crucial for identifying low-risk alleles.
- Single Nucleotide Polymorphisms (SNPs): Single base-pair variations in DNA sequence. These are the most common type of genetic variation and can occur anywhere in the genome, including promoter regions (affecting gene expression) and introns (non-coding regions).
- Low-risk alleles: SNPs identified through GWAS that individually contribute a small increase in disease risk. Crucially, their cumulative effect can significantly impact disease development.
- Oncogenes and Tumor Suppressor Genes: Genes that, when mutated, can contribute to cancer development. Oncogenes promote cell growth, while tumor suppressor genes inhibit it.
- Genetically Engineered Mouse Models (GEMMs): Mice genetically modified to mimic human diseases, allowing researchers to study disease mechanisms and test therapeutic strategies.
The text focuses on the discovery of low-risk alleles for colon cancer via GWAS. These SNPs are frequently located in:
- Promoter regions: Affecting gene expression levels of key genes.
- Introns: Although not directly coding for proteins, introns can impact gene expression through regulatory mechanisms.
- MYC oncogene: An oncogene whose over-expression is implicated in many cancers.
- Bone Morphogenetic Protein (BMP) signaling pathway: A crucial pathway involved in cell growth and differentiation; disruption can lead to uncontrolled cell growth.
The use of GEMMs is crucial in demonstrating the impact of these seemingly insignificant low-risk alleles. Manipulating these SNPs in GEMMs has shown profound effects on tumor development, suggesting that even small genetic variations can contribute substantially to cancer initiation and progression.
IV. Clinical Implications:
The discovery of disease-associated SNPs, even low-risk ones, holds important clinical implications. Individuals carrying these SNPs may require:
- Increased screening: More frequent colonoscopies or other screening methods to detect cancer early.
0 Comments
